Skip to main content
logo
Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
9.82
+0.05 (0.51%)
At close: Sep 28, 2026, 4:00 PM EDT
9.82
0.00 (0.00%)
After-hours: Sep 28, 2026, 4:28 PM EDT

Puma Biotechnology Revenue

Puma Biotechnology had revenue of $56.50M in the quarter ending June 30, 2026, with 7.75% growth. This brings the company's revenue in the last twelve months to $231.24M, down -2.86% year-over-year. In the year 2025, Puma Biotechnology had annual revenue of $228.37M, down -0.91%.

Revenue (ttm)
$231.24M
Revenue Growth
-2.86%
P/S Ratio
2.19
Revenue / Employee
$1,291,866
Employees
179
Market Cap
506.91M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025228.37M-2.10M-0.91%
Dec 31, 2024230.47M-5.17M-2.19%
Dec 31, 2023235.64M7.61M3.34%
Dec 31, 2022228.03M-25.12M-9.92%
Dec 31, 2021253.16M28.05M12.46%
Dec 31, 2020225.11M-47.15M-17.32%
Dec 31, 2019272.26M21.27M8.47%
Dec 31, 2018250.99M223.31M806.60%
Dec 31, 201727.69M--
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Arvinas316.70M
REGENXBIO174.48M
Autolus Therapeutics117.39M
Assembly Biosciences74.85M
Capricor Therapeutics11.13M
Prime Medicine4.07M
ProKidney818.00K
Revenue Rankings

PBYI News

More News